ARTICLES BY THIS AUTHOR
- 2/19/2021
Report: Pfizer asking FDA to let its COVID-19 vaccine be stored at higher temps
Pfizer and BioNTech SE have asked the Food and Drug Administration to relax requirements for their COVID-19 vaccine to be stored at ultra-low temperatures, potentially allowing for it to be kept in pharmacy freezers. - 2/19/2021
Camber releases generic Northera
Droxidopa capsules are available from Camber in a dosage strength of 300 mg in a 90-count bottle. - 2/19/2021
CVS Health addresses COVID-19 vaccine equity, education
The retailer is partnering with the YMCA, Lyft, clinics and faith-based organizations to increase access to COVID-19 vaccinations for vulnerable communities. - 2/18/2021
NACDS names Ayotte SVP of pharmacy, transformation and advocacy
Michael Ayotte, a former CVS executive, will lead the National Association of Chain Drug Stores’ advancement of state pharmacy scope of practice and operations, as well as opioid abuse prevention in the state regulatory and legislative arenas. - 2/24/2021
Hikma debuts thiamine hydrochloride injection
Thiamine hydrochloride injection had a market value of approximately $33 million in the 12 months ended November 2020, according to IQVIA. - 2/18/2021
Dr. Reddy's intros generic Prolixin
The Prolixin brand and generic had a market value of $134 million for the 12 months ended December 2020, according to IQVIA. - 2/18/2021
Almirall launches Klisyri
Almirall's Klisyri represents a significant step forward in the treatment of AK due to its short treatment protocol of a once-daily application for 5 days. - 2/19/2021
Keycentrix taps Binny John as VP of software development
Former McKesson executive Binny John, will lead Keycentrix’s technology development in his role as vice president of software development. - 2/17/2021
White House: Pharmacies to receive 2M COVID-19 vaccine doses per week
The federal government is increasing its vaccine supply to 13.5 million doses per week, and pharmacies will be receiving 2 million doses per week, according to White House press secretary Jen Psaki. - 2/17/2021
ANI expands leadership team with 3 executive appointments
ANI's new executive team includes Christopher Mutz as chief commercial officer and head of rare diseases, Ori Gutwerg as senior vice president of generics, and Davinder Singh as general manager of Canadian operations.